EP 1435917 A1 20040714 - SOLID PHARMACEUTICAL FORMULATION FOR A PIPERAZINE UREA DERIVATIVE
Title (en)
SOLID PHARMACEUTICAL FORMULATION FOR A PIPERAZINE UREA DERIVATIVE
Title (de)
FESTE ARZNEIMITTELFORMULIERUNG FÜR EIN PIPERAZINHARNSTOFFDERIVAT
Title (fr)
FORMULATION PHARMACEUTIQUE SOLIDE D'UN DERIVE PIPERAZINE UREE
Publication
Application
Priority
- DE 10152351 A 20011018
- EP 0211229 W 20021007
Abstract (en)
[origin: WO03035037A1] The invention relates to a solid pharmaceutical formulation that contains (2R)-1-((4-chloro-2-(ureido)phenoxy)methyl)carbon yl-2-methyl-4-(4-fluorobenzyl)piperazine or a salt thereof.
IPC 1-7
A61K 9/16; A61K 9/20; A61K 9/50; A61K 31/495; A61P 17/00; A61P 17/06; A61P 19/02; A61P 25/00
IPC 8 full level
A61K 9/14 (2006.01); A61K 9/16 (2006.01); A61K 9/20 (2006.01); A61K 31/495 (2006.01); A61K 47/04 (2006.01); A61K 47/10 (2006.01); A61K 47/12 (2006.01); A61K 47/20 (2006.01); A61K 47/32 (2006.01); A61K 47/34 (2006.01); A61K 47/36 (2006.01); A61K 47/38 (2006.01); A61P 17/00 (2006.01); A61P 17/06 (2006.01); A61P 19/02 (2006.01); A61P 25/00 (2006.01); A61P 29/00 (2006.01); A61P 37/08 (2006.01)
CPC (source: EP KR)
A61K 9/16 (2013.01 - KR); A61K 9/1652 (2013.01 - EP); A61K 9/2018 (2013.01 - EP); A61K 9/2027 (2013.01 - EP); A61K 31/495 (2013.01 - EP); A61P 9/00 (2017.12 - EP); A61P 17/00 (2017.12 - EP); A61P 17/06 (2017.12 - EP); A61P 19/02 (2017.12 - EP); A61P 25/00 (2017.12 - EP); A61P 29/00 (2017.12 - EP); A61P 37/08 (2017.12 - EP); A61K 9/1635 (2013.01 - EP); A61K 9/2054 (2013.01 - EP)
Citation (search report)
See references of WO 03035037A1
Citation (examination)
WO 9940061 A2 19990812 - PFIZER PROD INC [US], et al
Designated contracting state (EPC)
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR IE IT LI LU MC NL PT SE SK TR
DOCDB simple family (publication)
WO 03035037 A1 20030501; AR 037111 A1 20041020; AU 2002333896 A2 20030506; AU 2002333896 B2 20070726; BR 0213340 A 20041005; CA 2463951 A1 20030501; CN 1571660 A 20050126; CO 5580740 A2 20051130; DE 10152351 A1 20030508; DE 10152351 B4 20050922; EC SP045108 A 20040628; EP 1435917 A1 20040714; HR P20040435 A2 20050630; IL 161166 A0 20040831; JP 2005506365 A 20050303; KR 20040047920 A 20040605; MX PA04003522 A 20040723; NO 20042022 L 20040514; NZ 532287 A 20070427; PE 20030472 A1 20030616; PL 367987 A1 20050321; RS 32204 A 20061027; RU 2004115328 A 20050610; RU 2311172 C2 20071127; UY 27500 A1 20030630; ZA 200403781 B 20041129
DOCDB simple family (application)
EP 0211229 W 20021007; AR P020103929 A 20021018; AU 2002333896 A 20021007; BR 0213340 A 20021007; CA 2463951 A 20021007; CN 02820512 A 20021007; CO 04044345 A 20040513; DE 10152351 A 20011018; EC SP045108 A 20040517; EP 02801884 A 20021007; HR P20040435 A 20040517; IL 16116602 A 20021007; JP 2003537604 A 20021007; KR 20047005591 A 20021007; MX PA04003522 A 20021007; NO 20042022 A 20040514; NZ 53228702 A 20021007; PE 2002001027 A 20021017; PL 36798702 A 20021007; RU 2004115328 A 20021007; UY 27500 A 20021017; YU P32204 A 20021007; ZA 200403781 A 20040517